FDA decision on the companies product Twirla. Womans contraceptive patch BRUDAC ADcomm voted 14-1 in favor. 200mmil marketcap with a 4bill addressable market. Chasing approval since 2013. Approval IS NOT for certain. They could be issued a CRL. Could go much higher on approval. Manage your risk accordingly.